Smith Thornton Advisors’s Amgen AMGN Stock Holding History

Smith Thornton Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$389K	Sell	1,080 -82	-7%	-$28.1K	0.17%	101
2026 Q1	$409K	Sell	1,162 -11	-0.9%	-$3.92K	0.21%	99
2025 Q4	$384K	Buy	1,173 +46	+4%	+$14.6K	0.2%	102
2025 Q3	$318K	Sell	1,127 -145	-11%	-$42.1K	0.17%	110
2025 Q2	$355K	Buy	1,272 +25	+2%	+$7.08K	0.2%	102
2025 Q1	$389K	Buy	1,247 +62	+5%	+$18.3K	0.24%	89
2024 Q4	$309K	Buy	1,185 +412	+53%	+$122K	0.2%	111
2024 Q3	$249K	Hold	773	–	–	0.16%	119
2024 Q2	$242K	Buy	+773	New	+$227K	0.18%	114

Other funds holding AMGN

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFM

Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

SMDAM

Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return

Smith Thornton Advisors's AMGN Position: Q2 2026 in Review

Smith Thornton Advisors reduced its Amgen (AMGN) stake by 7.1% in Q2 2026, selling an estimated $28.1K and leaving 1,080 shares worth $389K. The position accounts for 0.17% of the portfolio, ranked #101.

Smith Thornton Advisors first reported a position in AMGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $409K in Q1 2026. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Smith Thornton Advisors held 1,080 shares of Amgen worth $389K as of Q2 2026.
Smith Thornton Advisors sold 82 Amgen shares in Q2 2026, an estimated $28.1K.
Amgen made up 0.17% of Smith Thornton Advisors's portfolio in Q2 2026, its #101 holding.
Smith Thornton Advisors first reported a position in Amgen in Q2 2024 and has held it in 9 quarters since.
Smith Thornton Advisors's Amgen position peaked at $409K in Q1 2026.
1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Smith Thornton Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.